Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
GENinCode UK Ltd. ( (GB:GENI) ) has provided an announcement.
GENinCode Plc announced that all resolutions were passed at their Annual General Meeting held in Oxford, UK. This development underscores the company’s continued focus on advancing its predictive genetics technology in the prevention of cardiovascular disease and ovarian cancer, potentially strengthening its market position and stakeholder confidence.
More about GENinCode UK Ltd.
GENinCode Plc is a UK-based company specializing in genetic risk assessment for cardiovascular disease and ovarian cancer. The company operates in the UK, Europe, and the United States, providing predictive technology that combines clinical algorithms and AI bioinformatics to offer preventive care and treatment strategies.
Average Trading Volume: 678,420
Technical Sentiment Signal: Sell
Current Market Cap: £6.45M
Learn more about GENI stock on TipRanks’ Stock Analysis page.